These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30763123)

  • 1. 'Conceivably Neglected' - Are prescribers sufficiently aware of the risks of prescribing sodium valproate to women with mental illness?
    Perera C; Patterson S; Bruxner G
    Australas Psychiatry; 2019 Apr; 27(2):125-128. PubMed ID: 30763123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
    Macfarlane A; Greenhalgh T
    BMC Pregnancy Childbirth; 2018 Jun; 18(1):200. PubMed ID: 29859057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.
    Paton C; Cookson J; Ferrier IN; Bhatti S; Fagan E; Barnes TRE
    BMJ Open; 2018 Apr; 8(4):e020450. PubMed ID: 29654033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study.
    Gaudio M; Konstantara E; Joy M; van Vlymen J; de Lusignan S
    BMC Pregnancy Childbirth; 2022 Jan; 22(1):73. PubMed ID: 35086478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive recommendations on the use of valproic acid in pregnant or gestational women to be very present.
    García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment; 2017; 10(3):129-133. PubMed ID: 28688547
    [No Abstract]   [Full Text] [Related]  

  • 6. Sodium valproate prescription to women of childbearing age in a New Zealand inpatient psychiatric unit.
    Goldspink R; Pumipi T; Dey S; Menkes DB
    Australas Psychiatry; 2020 Oct; 28(5):555-558. PubMed ID: 32586113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prescribing valproate to girls and women of childbearing age in Germany : Analysis of trends based on claims data].
    Wentzell N; Haug U; Schink T; Engel S; Liebentraut J; Linder R; Onken M; Schaefer C; Dathe K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Aug; 61(8):1022-1029. PubMed ID: 29922910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should women of childbearing potential be prescribed valproate? a call to action.
    Balon R; Riba M
    J Clin Psychiatry; 2016 Apr; 77(4):525-6. PubMed ID: 27137420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Caution and warning: About valproate and pregnancy].
    Masson M; Huberfeld G; Richa S; Henry C; Gaillard R
    Encephale; 2016 Oct; 42(5):391-394. PubMed ID: 27842894
    [No Abstract]   [Full Text] [Related]  

  • 10. France bans sodium valproate use in case of pregnancy.
    Casassus B
    Lancet; 2017 Jul; 390(10091):217. PubMed ID: 28721869
    [No Abstract]   [Full Text] [Related]  

  • 11. Valproate: life-saving, life-changing.
    Thomas RH
    Clin Med (Lond); 2018 Apr; 18(Suppl 2):s1-s8. PubMed ID: 29700085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium valproate and the fetus: a case study and review of the literature.
    Smith J; Whitehall J
    Neonatal Netw; 2009; 28(6):363-7. PubMed ID: 19892633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate and babies.
    Whitehall J; Smith J
    Aust N Z J Psychiatry; 2008 Sep; 42(9):837. PubMed ID: 18696289
    [No Abstract]   [Full Text] [Related]  

  • 14. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
    Tomson T; Perucca E; Battino D
    Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weighing the risks of valproate in women who could become pregnant.
    Angus-Leppan H; Liu RSN
    BMJ; 2018 Apr; 361():k1596. PubMed ID: 29669717
    [No Abstract]   [Full Text] [Related]  

  • 16. Dangers of valproate in pregnancy.
    Wieck A; Jones S
    BMJ; 2018 Apr; 361():k1609. PubMed ID: 29669728
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of valproate in women of childbearing potential: pre- and post-NICE bipolar guidelines.
    Vasudev K; Mead A
    Arch Womens Ment Health; 2010 Aug; 13(4):371-2. PubMed ID: 20440523
    [No Abstract]   [Full Text] [Related]  

  • 18. Did advice on the prescription of sodium valproate reduce prescriptions to women? An observational study in three European countries between 2007 and 2016.
    Charlton R; Damase-Michel C; Hurault-Delarue C; Gini R; Loane M; Pierini A; Puccini A; Neville A; Snowball J; Morris JK;
    Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1519-1528. PubMed ID: 31452307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prescribing of antiepileptic drugs for pregnant Australian women.
    Vajda FJ; Horgan D; Hollingworth S; Graham J; Hitchcock AA; Roten A; O'Brien TJ; Lander CM; Eadie MJ
    Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):49-53. PubMed ID: 21910695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic Acid in Women and Girls of Childbearing Age.
    Gotlib D; Ramaswamy R; Kurlander JE; DeRiggi A; Riba M
    Curr Psychiatry Rep; 2017 Sep; 19(9):58. PubMed ID: 28726062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.